ADC Therapeutics SA
€1.290
EUR
Last updated on --.
24h volume466.06K
24h highest1.4752 EUR
24h lowest1.0520 EUR
24h Price movement-51.30%
ADCT recent prices
24 Hours
-51.30%-€1.360
30 days
-54.26%-€1.755
60 days
-53.13%-€1.678
90 days
-58.15%-€2.056
Key data
Previous close2.6494 EUR
Market cap371.99M EUR
Volume466.06K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.92902 EUR
Net income (FY)-117.84M EUR
Revenue (FY)68.11M EUR
Last report dateMay 4, 2026
About ADC Therapeutics SA
HeadquartersEPALINGES
Employees (FY)193.00
Revenue per employee (FY)352.88K EUR
Net income per employee (FY)-610.56K EUR
Listed onNew York Stock Exchange
ADCT conversion tables
 |  |
|---|---|
| 0.5 ADCT | 0.64515 EUR |
| 1 ADCT | 1.290 EUR |
| 5 ADCT | 6.451 EUR |
| 10 ADCT | 12.9 EUR |
| |
|---|---|
| 0.5 EUR | 0.38751 ADCT |
| 1 EUR | 0.77501 ADCT |
| 5 EUR | 3.875 ADCT |
| 10 EUR | 7.750 ADCT |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
ADCT is trading at €1.290, -51.30% over the last 24 hours. Track live moves on the price chart at the top of this page.
The ADCT stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. ADCT is currently trading at €1.290, -51.30% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on ADCT price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. ADCT's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from ADCT; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against ADCT's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
ADC Therapeutics SA's market cap is currently 371.99M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume466.06K
24h highest1.4752 EUR
24h lowest1.0520 EUR
24h Price movement-51.30%
Start trade with ADCT Perpetual
Sign up to trade